Human tests of COVID-19 Vaccine begins soon on 375 people: COVAXIN
India’s first indigenous coronavirus vaccine ‘COVAXIN’ successfully enters human trials. The vaccine will be tested on more than 1,100 people in the first two phases of clinical trials. Bharat Biotech says the vaccine has shown safety and immune response in preclinical studies. New Delhi: Hyderabad-based Bharat Biotech is expected to begin human trials of its COVID-19 […]
Continue Reading